1-7 of 7
Hervé Tilly
Close
Sort by
Journal Articles

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérome Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloé Antier, Julien Lazarovici, Emilie Lévêque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Hervé Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7331–7345.
https://doi.org/10.1182/bloodadvances.2023011169
Published: 2023
Includes: Supplemental data
Journal Articles

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis

Clinical Trials & Observations
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loïc Renaud, Loic Chartier, Nicolas Ketterer, Christian Récher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Franck Morschhauser, Bertram Glass, Nicolas Mounier, Herve Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Molina, Marita Ziepert, Norbert Schmitz
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3968–3977.
https://doi.org/10.1182/bloodadvances.2022008888
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus, Aurélien Belot, Lucie Oberic, David Sibon, Hervé Ghesquières, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Jo Molina, André Bosly, Clémentine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6169–6179.
https://doi.org/10.1182/bloodadvances.2022007609
Published: 2022
Includes: Supplemental data
Journal Articles

A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma

Catherine Thieblemont, Loic Chartier, Ulrich Dührsen, Umberto Vitolo, Sally F. Barrington, Jan M. Zaucha, Laetitia Vercellino, Maria Gomes Silva, Ines Patrocinio-Carvalho, Pierre Decazes, Pierre-Julien Viailly, Herve Tilly, Alina Berriolo-Riedinger, Oliver Casasnovas, Andreas Hüttmann, Hajira Ilyas, N. George Mikhaeel, Joel Dunn, Anne-Ségolène Cottereau, Christine Schmitz, Lale Kostakoglu, Joseph N. Paulson, Tina Nielsen, Michael Meignan
Journal: Blood Advances
Blood Adv (2022) 6 (23): 5995–6004.
https://doi.org/10.1182/bloodadvances.2021006923
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data